Department of Neurology, National Neuroscience Institute, Singapore City, Singapore.
Duke-NUS Medical School, Singapore City, Singapore.
Eur J Neurol. 2023 Jun;30(6):1658-1666. doi: 10.1111/ene.15785. Epub 2023 Mar 26.
A broad list of variables associated with mild cognitive impairment (MCI) in Parkinson disease (PD) have been investigated separately. However, there is as yet no study including all of them to assess variable importance. Shapley variable importance cloud (ShapleyVIC) can robustly assess variable importance while accounting for correlation between variables. Objectives of this study were (i) to prioritize the important variables associated with PD-MCI and (ii) to explore new blood biomarkers related to PD-MCI.
ShapleyVIC-assisted variable selection was used to identify a subset of variables from 41 variables potentially associated with PD-MCI in a cross-sectional study. Backward selection was used to further identify the variables associated with PD-MCI. Relative risk was used to quantify the association of final associated variables and PD-MCI in the final multivariable log-binomial regression model.
Among 41 variables analysed, 22 variables were identified as significantly important variables associated with PD-MCI and eight variables were subsequently selected in the final model, indicating fewer years of education, shorter history of hypertension, higher Movement Disorder Society-Unified Parkinson's Disease Rating Scale motor score, higher levels of triglyceride (TG) and apolipoprotein A1 (ApoA1), and SNCA rs6826785 noncarrier status were associated with increased risk of PD-MCI (p < 0.05).
Our study highlighted the strong association between TG, ApoA1, SNCA rs6826785, and PD-MCI by machine learning approach. Screening and management of high TG and ApoA1 levels might help prevent cognitive impairment in early PD patients. SNCA rs6826785 could be a novel therapeutic target for PD-MCI. ShapleyVIC-assisted variable selection is a novel and robust alternative to traditional approaches for future clinical study to prioritize the variables of interest.
已有大量与帕金森病(PD)轻度认知障碍(MCI)相关的变量被分别研究。然而,目前还没有研究将所有这些变量纳入其中来评估变量的重要性。Shapley 变量重要性云(ShapleyVIC)可以稳健地评估变量的重要性,同时考虑到变量之间的相关性。本研究的目的是(i)确定与 PD-MCI 相关的重要变量,并(ii)探索与 PD-MCI 相关的新血液生物标志物。
我们使用 ShapleyVIC 辅助变量选择从横断面研究中与 PD-MCI 相关的 41 个潜在变量中选择一个变量子集。然后使用向后选择进一步确定与 PD-MCI 相关的变量。相对风险用于量化最终相关变量与 PD-MCI 在最终多变量对数二项回归模型中的关联。
在分析的 41 个变量中,有 22 个变量被确定为与 PD-MCI 显著相关的重要变量,随后在最终模型中选择了 8 个变量,表明受教育年限较少、高血压病史较短、较高的运动障碍协会统一帕金森病评定量表运动评分、较高的甘油三酯(TG)和载脂蛋白 A1(ApoA1)水平,以及 SNCA rs6826785 非携带者状态与 PD-MCI 的风险增加相关(p<0.05)。
我们的研究通过机器学习方法强调了 TG、ApoA1、SNCA rs6826785 与 PD-MCI 之间的强烈关联。筛查和管理高 TG 和 ApoA1 水平可能有助于预防早期 PD 患者的认知障碍。SNCA rs6826785 可能是 PD-MCI 的一个新的治疗靶点。ShapleyVIC 辅助变量选择是未来临床研究中一种新颖且稳健的替代传统方法,可优先考虑感兴趣的变量。